Stilla Technologies

Stilla Technologies is a leading company in multiplex digital PCR (dPCR), a cutting-edge technology that enables precise and sensitive genetic analysis. They offer a comprehensive range of dPCR solutions for various applications, including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing. Stilla's commitment to innovation is reflected in their groundbreaking Crystal Digital PCR™ technology and their portfolio of dPCR systems, including the industry's first to feature three, six, and seven fluorescent channels.

Stilla's mission is to improve health by offering high-precision genetic analysis solutions to researchers and clinicians worldwide. Their global team, with expertise in microfluidics, chemistry, molecular biology, and computer science, is passionate about developing new products for advanced genetic testing and analysis. The company has US headquarters in Boston, MA, and European headquarters in Paris, France, with strategic distribution and business partnerships in China and throughout EMEA.

Stilla Technologies is a biotechnology company dedicated to improving human health through high-precision genetic analysis solutions. Their mission is to provide researchers and clinicians worldwide with cutting-edge tools that enable advanced genetic testing and analysis, ultimately leading to better human health outcomes.

Stilla Technologies promotes a culture of innovation and collaboration, fostering a global, multidisciplinary team passionate about developing cutting-edge life science products. They are committed to improving human health outcomes through deep technological innovation and embrace a professional equity index, reflecting a dedication to gender equality within the company.

Stilla Technologies is committed to promoting diversity, equity, and inclusion within its workforce. This commitment is demonstrated through the company’s Professional Equity Index, which scored 92/100 in 2023. While the exact indicators are not specified, this high score suggests the company prioritizes practices that ensure fair and equitable treatment for all employees regardless of gender, race, or any other protected characteristic.